Key result
Low extracellular magnesium upregulates proto-oncogenes and VSMC proliferation via calcium and PKC signaling.
Answers are grounded in this paper and cite their sources.
Proto-oncogene (c-fos, c-jun) and nuclear factor-kappa B (NF-kappaB) expression, as well as DNA synthesis, in aortic and cerebral vascular smooth muscle cells (VSMCs) were upregulated by a decrease in extracellular magnesium ions ([Mg2+]o). Upregulation of these transcriptional factors was inversely proportional to the [Mg2+]o and occurred over the pathophysiologic range of serum Mg2+ found in patients presenting with hypertension, ischemic heart disease, and stroke. Removal of extracellular Ca2+ ([Ca2+]o), use of nifedipine or protein kinase C (PKC) inhibitors prevented the upregulation of the proto-oncogenes and DNA synthesis in VSMCs. These data show that [Mg2+]o may be an important, heretofore, overlooked natural modulator of proto-oncogene and NF-kappaB expression in VSMCs and that Ca2+ and PKC may play critical roles in induction of c-fos and c-jun in VSMCs induced by a decrease in [Mg2+]o. These results point to a role for low serum Mg2+ in potential development of hypertension, atherogenesis, vascular disease, and stroke.
No takes yet. Share an insight, caveat, or question.
B ALTURA (2003) studied Hypertension, atherogenesis, vascular disease, and stroke (in vitro model). Low extracellular magnesium ions ([Mg2+]o), Ca2+ removal, nifedipine, or protein kinase C (PKC) inhibitors was evaluated on Proto-oncogene (c-fos, c-jun) and NF-kappaB expression, and DNA synthesis in VSMCs. Decreased extracellular magnesium upregulated c-fos, c-jun, NF-kappaB expression, and DNA synthesis in vascular smooth muscle cells, an effect prevented by nifedipine, PKC inhibitors, or Ca2+ removal.
Synapse has enriched 10 related papers. Consider them for comparative context: